Holdings of Davern Capital Partners, LP
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 15 in 5 countries
- Top ten
- 89.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Pfizer Inc | 1,593,942 | 44.8M $ | |
| 2 | Regeneron Pharmaceuticals, Inc. | 44,800 | 34.6M $ | |
| 3 | Insmed Inc | 182,562 | 29.9M $ | |
| 4 | Ionis Pharmaceuticals Inc | 386,903 | 29.1M $ | |
| 5 | Natera Inc | 143,966 | 28.8M $ | |
| 6 | BioNTech SE | 305,055 | 27.1M $ | |
| 7 | Argenx SE | 35,045 | 25.6M $ | |
| 8 | Eli Lilly & Co | 27,279 | 25.1M $ | |
| 9 | LEGEND BIOTECH CORP | 1,314,748 | 23.8M $ | |
| 10 | Mineralys Therapeutics Inc | 447,153 | 12.1M $ | |
| 11 | Abivax SA | 78,125 | 8.7M $ | |
| 12 | Generate Biomedicines Inc | 591,800 | 7.4M $ | |
| 13 | PROCEPT BIOROBOTICS CORP | 261,200 | 6.5M $ | |
| 14 | Structure Therapeutics Inc | 126,461 | 6.1M $ | |
| 15 | Viridian Therapeutics Inc | 302,457 | 5.9M $ |
Sector breakdown
- Health care 69.0 %
- Unattributed 31.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 73.0 %
- Germany 8.6 %
- Netherlands 8.1 %
- Cayman Islands 7.5 %
- France 2.8 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 11 | 230.2M $ | 72.99 % |
| 2 | Germany | 1 | 27.1M $ | 8.60 % |
| 3 | Netherlands | 1 | 25.6M $ | 8.11 % |
| 4 | Cayman Islands | 1 | 23.8M $ | 7.54 % |
| 5 | France | 1 | 8.7M $ | 2.76 % |
Cite this page
Titelia. "Holdings of Davern Capital Partners, LP". https://titelia.com/en/funds/US13F2003147